Publications by authors named "Anna Teschemaker"

Claim this Profile
A
A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
George Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, Lee Ann Dietz, Chanh Huynh, Anna Teschemaker

J Med Econ· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study.
Lindsey E Roeker, Yi Han, Anna Teschemaker, Anthony R Mato, Meghan C Thompson

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Anna Teschemaker

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Shreekant Parasuraman, Ellen Thiel, Julie Park, Anna Teschemaker

J Med Econ· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Milind Javle, Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Anna Teschemaker

Oncologist· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States.
Cheryl Neslusan, Anna Teschemaker, Michael Willis, Pierre Johansen, Lien Vo

Diabetes Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Canagliflozin versus Sitagliptin When Added to Metformin and Sulfonylurea in Type 2 Diabetes in Canada.
Suthakar Sabapathy, Cheryl Neslusan, Kim Yoong, Anna Teschemaker, Pierre Johansen

J Popul Ther Clin Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico.
Cheryl Neslusan, Anna Teschemaker, Pierre Johansen, Michael Willis, Atanacio Valencia-Mendoza

Value Health Reg Issues· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label prescribing patterns of antidepressants in children and adolescents.
Euni Lee, Anna R Teschemaker, Rosemary Johann-Liang, Gina Bazemore, Martin Yoon

Pharmacoepidemiol Drug Saf· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
Anna Teschemaker, Euni Lee, Zhenyi Xue, Anthony K Wutoh

Am J Geriatr Pharmacother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis